CT
CTVA.US Corteva Inc
- Market cap
- USD 6.29B
- P/E
- 7.1x
- P/B
- 0.25x
- ROE
- 7.1%
- Dividend yield
- 7.55%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CTVA.US undervalued?
Graham numberThe Graham number of Corteva Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Corteva Inc fundamental analysis
No fundamental analysis for Corteva Inc yet.
Corteva Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Corteva Inc
Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects…
Full company profileCorteva Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Corteva Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 14.0B | 14.2B | 14.3B | 13.8B | 14.2B | 15.7B | 17.5B | 17.2B | 16.9B | 17.4B | 18.3B |
| Gross Profit | 5.65B | 5.84B | 4.34B | 5.27B | 5.71B | 6.44B | 7.02B | 17.2B | 7.38B | 8.23B | 9.23B |
| Operating Income | 886M | 188M | -448M | 584M | 843M | 1.32B | 1.93B | 941M | 2.10B | 2.62B | 3.45B |
| EBITDA | 1.59B | 1.24B | -3.68B | 1.42B | 1.90B | 3.62B | 2.73B | 941M | 2.74B | 3.07B | 4.32B |
| Net Income | 503M | 2.53B | -5.07B | -959M | 681M | 1.76B | 1.15B | 735M | 907M | 1.09B | 1.75B |
| EPS | 0.10 | 0.51 | -6.76 | -0.19 | 0.14 | 0.36 | 1.58 | 1.03 | 1.30 | 1.61 | 2.62 |
| Balance Sheet | |||||||||||
| Total Assets | 0.00 | 113B | 42.9B | 42.4B | 42.6B | 42.3B | 42.6B | 43.0B | 40.8B | 42.8B | 43.0B |
| Total Liabilities | 0.00 | 38.0B | 19.1B | 17.8B | 17.6B | 16.7B | 17.1B | 17.7B | 16.8B | 18.5B | 18.3B |
| Shareholders' Equity | 0.00 | 74.8B | 23.8B | 24.3B | 24.8B | 25.4B | 25.3B | 25.0B | 23.8B | 24.1B | 24.5B |
| Cash & Short-term Investments | 0.00 | 8.76B | 2.13B | 1.77B | 3.80B | 4.55B | 3.32B | 2.74B | 3.17B | 4.53B | 3.93B |
| Total Debt | - | 13.1B | 7.67B | 127M | 1.11B | 1.12B | 1.31B | 2.49B | 2.70B | 2.58B | 7.45B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.36B | 247M | 483M | 1.07B | 2.06B | 2.73B | 872M | 1.77B | 2.15B | 3.41B | -5.26B |
| Capital Expenditure | 1.02B | 1.11B | 1.50B | 1.16B | 475M | 573M | 605M | 595M | 597M | 591M | 472M |
| Free Cash Flow | 2.34B | -866M | -1.02B | -93.0M | 1.59B | 2.15B | 267M | 1.17B | 1.55B | 2.82B | -5.74B |
| Ratios | |||||||||||
| ROE | - | 3.4% | -21.3% | -3.9% | 2.7% | 6.9% | 4.5% | 2.9% | 3.8% | 4.5% | 7.1% |
| ROA | - | 2.2% | -11.8% | -2.3% | 1.6% | 4.2% | 2.7% | 1.7% | 2.2% | 2.6% | 4.1% |
| Net Profit Margin | 3.6% | 17.8% | -35.5% | -6.9% | 4.8% | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% | 9.5% |
| Debt to Equity | - | 0.17x | 0.32x | 0.01x | 0.04x | 0.04x | 0.05x | 0.10x | 0.11x | 0.11x | 0.30x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Corteva Inc dividends
- Dividend yield
- 7.55%
- Forward dividend
- 0.72 USD
- Payout ratio
- 43.4%
- Ex-dividend date
- Dec 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 475M | 0.70 | 43.4% |
| 2024 | USD 458M | 0.66 | 50.5% |
| 2023 | USD 439M | 0.62 | 59.7% |
| 2022 | USD 418M | 0.58 | 36.4% |
| 2021 | USD 397M | 0.08 | 22.6% |
| 2020 | USD 388M | 0.08 | 57.0% |
| 2019 | USD 511M | 0.10 | - |
| 2018 | USD 2.81B | 3.74 | - |
| 2017 | USD 988M | 0.20 | 39.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6665:1000 on Oct 1, 2026.
Who owns Corteva Inc
- Insiders 0.16%
- Institutions 93.03%
- Public & others 6.81%
- Shares outstanding 667M
- Free float 667M
Top funds holding CTVA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 24.0M | 3.59% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 21.2M | 3.17% | -0.82% | Sep 2026 |
| Vanguard 500 Index Investor | 17.5M | 2.63% | -1.38% | Sep 2026 |
| Fidelity Contrafund | 15.4M | 2.31% | +12.37% | Sep 2026 |
| Vanguard MStar Mid Cap Index Instl | 14.3M | 2.14% | -1.64% | Sep 2026 |
| American Funds Washington Mutual A | 12.7M | 1.90% | +11.10% | Sep 2026 |
| Vanguard Windsor II Inv | 10.3M | 1.55% | -10.44% | Sep 2026 |
| Fidelity 500 Index | 8.67M | 1.30% | -0.13% | Sep 2026 |
| American Funds New Perspective A | 7.02M | 1.05% | +54.59% | Sep 2026 |
| Vanguard MStar Value Index Investor | 6.35M | 0.95% | -0.93% | Sep 2026 |
| American Funds American Balanced A | 6.29M | 0.94% | 0.00% | Sep 2026 |
| American Funds Fundamental Invs A | 6.27M | 0.94% | +85.70% | Sep 2026 |
| Vanguard Wellington Inv | 6.27M | 0.94% | +8.04% | Sep 2026 |
| Oakmark Investor | 5.42M | 0.81% | -28.30% | Sep 2026 |
| American Funds New Economy A | 5.36M | 0.80% | +5.68% | Sep 2026 |
| Northern Trust MstarGlblUpstmNatrlResETF | 4.35M | 0.65% | 0.00% | Oct 2026 |
| Vanguard MStar Mid Cap Value ETF | 4.16M | 0.62% | -4.18% | Sep 2026 |
| Janus Henderson Enterprise D | 3.81M | 0.57% | -8.02% | Sep 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 3.62M | 0.54% | +0.05% | Oct 2026 |
| Vanguard Institutional Index I | 3.53M | 0.53% | -1.25% | Sep 2026 |
Top institutions holding CTVA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 53.8M | 8.07% | -1.58% | Jun 2026 |
| Vanguard Capital Management, LLC | 43.8M | 6.56% | -0.64% | Jun 2026 |
| Capital World Investors | 42.9M | 6.43% | +19.24% | Jun 2026 |
| FMR Inc | 41.1M | 6.16% | +17.44% | Jun 2026 |
| State Street Corp | 38.3M | 5.73% | +5.88% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 29.8M | 4.47% | -0.86% | Jun 2026 |
| Franklin Templeton Inc | 22.3M | 3.35% | +2.47% | Jun 2026 |
| Geode Capital Management, LLC | 18.9M | 2.83% | +0.94% | Jun 2026 |
| Aristotle Capital Management LLC | 17.8M | 2.66% | -5.66% | Jun 2026 |
| Harris Associates L.P. | 16.3M | 2.45% | -1.94% | Jun 2026 |
| Northern Trust Corp | 12.1M | 1.81% | -3.28% | Jun 2026 |
| Amvescap Plc. | 9.53M | 1.43% | -12.30% | Jun 2026 |
| Royal Bank of Canada | 9.21M | 1.38% | +23.48% | Jun 2026 |
| WCM Investment Management | 8.94M | 1.34% | +2.61% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 7.99M | 1.20% | -19.52% | Jun 2026 |
| State Farm Mutual Automobile Ins Co | 7.63M | 1.14% | 0.00% | Jun 2026 |
| Wellington Management Company LLP | 7.61M | 1.14% | +941.65% | Jun 2026 |
| The Goldman Sachs Group Inc | 7.11M | 1.07% | +2.86% | Jun 2026 |
| Jupiter Topco LLC | 6.43M | 0.96% | 0.00% | Jun 2026 |
| JPMorgan Chase & Co | 6.42M | 0.96% | +13.76% | Jun 2026 |
Corteva Inc company profile
- Company name
- Corteva Inc
- Ticker
- CTVA.US
- Exchange
- USA Stocks
- Listed since
- May 24, 2019
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 21,500
- Fiscal year end
- December
- Address
- 9330 Zionsville Road, Indianapolis, IN, United States, 46268
- Phone
- 833 267 8382
- Website
- corteva.com
About Corteva Inc
Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects, and diseases. The company offers herbicides, soybeans, cereals, fruits and vegetables, insecticides, nitrogen stabilizers, pasture, and a range management herbicides and biologicals and other nature-based products. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Corteva Inc management
7- Mr. Luther Clarence Kissam IVCEO & Director · born 1965
- Mr. Jeffrey RudolphChief Financial Officer · born 1983
- Mr. Ralph FordChief Integrated Operations Officer
- Mr. Reza Rasoulpour Ph.D.Chief Technology Officer
- Ms. Karen G. Narwold Esq.Chief Legal and Public Affairs Officer & Corporate Secretary · born 1960
- Ms. Jen SloanChief People Officer
- Ms. Brook CunninghamChief Commercial Officer · born 1981